DARE (Dare Bioscience) Total Assets: $27.83 Mil (As of Mar. 2026)

What is Dare Bioscience Total Assets?

Dare Bioscience DARE +0.96% 23 Total Assets is $27.83 Mil as of Mar. 2026. GuruFocus rates DARE with a GF Score™ of 23/100. The stock has 4 warning signs investors should review.

Dare Bioscience's Total Assets for the quarter that ended in Mar. 2026 was $27.83 Mil.

During the past 12 months, Dare Bioscience's average Total Assets Growth Rate was 12.30% per year. During the past 3 years, the average Total Assets Growth Rate was -5.30% per year. During the past 5 years, the average Total Assets Growth Rate was 20.20% per year.

During the past 13 years, Dare Bioscience's highest 3-Year average Total Assets Growth Rate was 59.40%. The lowest was -24.50%. And the median was 34.40%.

Total Assets is connected with ROA %. Dare Bioscience's annualized ROA % for the quarter that ended in Mar. 2026 was -39.80%. Total Assets is also linked to Revenue through Asset Turnover. Dare Bioscience's Asset Turnover for the quarter that ended in Mar. 2026 was 0.01.

Dare Bioscience (NAS:DARE) Total Assets Explanation

Total Assets is connected with ROA %.

Dare Bioscience's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %	=	Net Income (Q: Mar. 2026 )	/	( (Total Assets (Q: Dec. 2025 )	+	Total Assets (Q: Mar. 2026 ))	/ count )
	=	-12	/	( (32.475	+	27.828)	/ 2 )
	=	-12	/	30.1515
	=	-39.80 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Dare Bioscience's Asset Turnover for the quarter that ended in Mar. 2026 is

	Asset Turnover
=	Revenue (Q: Mar. 2026 )	/	( (Total Assets (Q: Dec. 2025 )	+	Total Assets (Q: Mar. 2026 ))	/ count )
=	0.152	/	( (32.475	+	27.828)	/ 2 )
=	0.152	/	30.1515
=	0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Dare Bioscience Total Assets Related Terms

Dare Bioscience Total Assets Historical Data

* Premium members only.

The historical data trend for Dare Bioscience's Total Assets can be seen below:

Dare Bioscience Total Assets Chart

Dare Bioscience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Assets

Get a 7-Day Free Trial

55.81

43.83

21.28

22.10

32.48

Dare Bioscience Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Assets	Get a 7-Day Free Trial															18.62	12.98	30.75	32.48	27.83

23GF Score

Dare Bioscience Inc DARE

Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Dare Bioscience Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Dare Bioscience's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets	=	Total Equity (A: Dec. 2025 )	+	Total Liabilities (A: Dec. 2025 )
	=	2.843	+	29.632
	=	32.48

Dare Bioscience's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2026 )	+	Total Liabilities (Q: Mar. 2026 )
	=	0.734	+	27.094
	=	27.83

Frequently Asked Questions Learn more about Total Assets →

What does a Total Assets of $27.83 Mil mean?

Dare Bioscience (DARE) has a Total Assets of $27.83 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Dare Bioscience and its competitors.

Is Dare Bioscience's Total Assets too high?

Dare Bioscience's current Total Assets is $27.83 Mil. Overall, Dare Bioscience has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.

How does Dare Bioscience's Total Assets compare to ATNM and NNVC?

Dare Bioscience's Total Assets of $27.83 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Assets for a Biotechnology company?

A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Assets mean?

A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Dare Bioscience and its competitors. Dare Bioscience's current Total Assets is $27.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Dare Bioscience stock overvalued right now?

Dare Bioscience (DARE) has a current Total Assets of $27.83 Mil. The current Total Assets is $27.83 Mil. Dare Bioscience's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Assets calculated?

Total Assets is calculated from a company's financial statements. For Dare Bioscience (DARE), the current Total Assets is $27.83 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dare Bioscience Business Description

Industry Healthcare Biotechnology

Comparable Companies ATNM NNVC LSTA SGMO LITS CRVO DYAI GRDX TVGN KYNB VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 3655 Nobel Drive, Suite 260, San Diego, CA, USA, 92122

Website https://www.darebioscience.com

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

23GF Score

Get the complete analysis for DARE

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.12

Price

View DARE Analysis

See Total Assets data for all stocks →